Interaction of μ-opioid antagonistic drugs with antiepileptics

Pharmacology and Toxicology

Volumn 78, Issue 4, 1996, Pages 264-268

  Frey, Hans Hasso ^a   Schicht, Sabine ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOCINNAMOX; CYPRODIME; MU OPIATE RECEPTOR; NALOXONE; OPIATE ANTAGONIST; PHENOBARBITAL; PHENYTOIN;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG INTERACTION; DRUG POTENTIATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANIMALIA;

EID: 0029670214     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1996.tb00215.x     Document Type: Article

References (24)

1. Aceto, M. D., E. R. Bowman, E. L. May, L. S. Harris, J. H. Woods, C. B. Smith, F. Medzihradsky & A. E. Jacobson: Very long-acting narcotic antagonists: the 14β-p-substituted cinnamoylaminomorphinones and their partial μ-agonist codeinone relatives. Arzneimittelforsch. 1989, 39, 570-575.
2. Burke, T. F., J. H. Woods, J. W. Lewis & F. Medzihradsky: Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and μ-receptor binding in mice. J. Pharmacol. Exp. Therap. 1994, 271, 715-721.
3. Comer, S. D., T. F. Burke, J. W. Lewis & J. H. Woods: Clocinnamox: A novel, systemically-active, irreversible opioid antagonist. J. Pharmacol. Exp. Therap. 1992, 262, 1051-1056.
4. Czuczwar, S. J. & H.-H. Frey: Effect of morphine and morphine-like analgesics on susceptibility to seizures in mice. Neuropharmacology 1986, 25, 465-469.
5. Foote, F. & K. Gale: Morphine potentiates seizures induced by GABA antagonists and attenuates seizures induced by electroshock in the rat. Eur. J. Pharmacol. 1983, 95, 259-264.
6. Foote, F. & K. Gale: Proconvulsant effect of morphine on seizures induced by pentylenetetrazol in the rat. Eur. J. Pharmacol. 1984, 105, 179-184.
7. Frenk, H.: Pro- and anticonvulsant actions of morphine and the endogenous opioids: involvement and interactions of multiple opiate and non-opiate systems. Brain Res. Rev. 1983, 6, 197-210.
8. Frey, H.-H.: Anticonvulsant effect of morphine and morphine-like analgesics in mongolian gerbils. Pharmacology 1986, 32, 335-339.
9. Frey, H.-H.: Interactions between morphine-like analgesics and anticonvulsant drugs. Pharmacology & Toxicology 1987, 60, 210-213.
10. Frey, H.-H.: Effect of μ- and κ-opioid agonists on the electroconvulsive seizure threshold in mice and antagonism by naloxone and MR 2266. Pharmacology & Toxicology 1988, 62, 150-154.
11. Frey, H.-H., S. J. Czuczwar & R. Scherkl: Morphine-like analgesics and convulsive threshold for pentetrazole in dogs. Arch. Int. Pharmacodyn. Therap. 1986, 283, 39-44.
12. Jackson, H. C. & D. J. Nutt: Opioid receptor involvement in the anticonvulsant action of phenytoin. Brit. J Pharmacol. 1992, 105 (Suppl.), 144P.
13. Jackson, H. C. & D. J. Nutt: Investigation of the involvement of opioid receptors in the action of anticonvulsants. Psychopharmacology 1993, 111, 486-490.
14. Kilian, M. & H.-H. Frey: Central monoamines and convulsive thresholds in mice and rats. Neuropharmacology 1973, 12, 681-692.
15. Kimball, A. W., W. T. Burnett, Jr. & D. G. Doherty: Chemical protection against ionizing radiation: I. Sampling methods for screening compounds in radiation protection studies with mice. Radiat. Res. 1957, 7, 1-12.
16. Korkmaz, S., E. Ljungblad & G. Wahlström: Interaction between flumazenil and the anesthetic effects of hexobarbital in the rat. Brain Res. 1995, 676, 371-377.
17. Litchfield, J. T., Jr. & F. Wilcoxon: A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Therap. 1949, 96, 99-113.
18. Löscher, W. & W. Göbel: Consecutive gas chromatographic determination of phenytoin, phenobarbital, primidone, phenylethylmalondiamide, carbamazepine, trimethadione, dimethadione, ethosuximide, and valproate from the same serum specimen. Epilepsia 1978, 19, 463-173.
19. Macdonald, R. L. & M. J. McLean: Anticonvulsant drugs: mechanisms of action. In: Basic mechanisms of the epilepsies. Molecular and cellular approaches. Advances in Neurology, vol. 44. Eds.: A. V. Delgado-Escueta, A. A. Ward, Jr., D. M. Woodbury & R. J. Porter. Raven Press, New York, 1986, 713-736.
20. Schicht, S.: Der Einfluβ von μ-Opioidagonisten und -antagonisten auf die Wirksamkeit von sechs klinisch gebräuchlichen Antiepileptika bei der Maus. Thesis, 1994, Free University Berlin, School of Veterinary Medicine.
21. Schmidhammer, H., W. P. Burkard, L. Eggstein-Aeppli & C. F. C. Smith: Synthesis and biological evaluation of 14-alkoxymorphinans. 2. (-)-N-(cyclopropylmethyl)-4,14-dimethoxymorphinan-6-one, a selective μ-opioid receptor antagonist. J. Med. Chem. 1989, 32, 418-421.
22. Swinyard, E. A.: Electrically induced convulsions. In: Experimental models of epilepsy: a manual for the laboratory worker. Eds.: A. D. Purpura, J. K. Penry, D. B. Tower, D. M. Woodbury & R. D. Walter. Raven Press, New York, 1972, pp. 433-458.
23. Takemori, A. E. & P. S. Portoghese: Comparative antagonism by naltrexone and naloxone of μ-, κ- and δ-agonists. Eur. J. Pharmacol. 1984, 104, 101-104.
24. Tortella, F. C., L. Robles & H. I. Mosberg: Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures. J. Pharmacol. Exp. Therap. 1987, 240, 571-577.